Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shai Erlich"'
Autor:
Segav Demirjian, Gorav Ailawadi, Martin Polinsky, Dani Bitran, Shuli Silberman, Stanton Keith Shernan, Michel Burnier, Marta Hamilton, Elizabeth Squiers, Shai Erlich, Daniel Rothenstein, Samina Khan, Lakhmir S. Chawla
Publikováno v:
Kidney International Reports, Vol 2, Iss 5, Pp 836-843 (2017)
Patients undergoing on-pump cardiac surgery are at an increased risk of acute kidney injury. QPI-1002, a small interfering ribonucleic acid, is under clinical development for the prevention of acute kidney injury. The safety, tolerability, and pharma
Externí odkaz:
https://doaj.org/article/f74d25425ae648c4aa53f8b008ae7f02
Autor:
David Corteville, Gábor Szabó, Nicolas Noiseux, C. Brown, C. David Mazer, Daniel Rothenstein, Bruce A. Molitoris, Madhav Swaminathan, Andre Lamy, Shai Erlich, Elizabeth C. Squiers, Matthias Thielmann, Lukas Lehner, Mohamed G. Atta
Publikováno v:
Circulation. 144:1133-1144
Background: Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA that temporarily inhibits p53-mediated
Autor:
Lakhmir S. Chawla, Segav Demirjian, Shai Erlich, Gorav Ailawadi, Samina Khan, Martin Polinsky, Marta Hamilton, Shuli Silberman, Stanton K. Shernan, Elizabeth C. Squiers, Dani Bitran, Michel Burnier, Daniel Rothenstein
Publikováno v:
Kidney international reports, vol. 2, no. 5, pp. 836-843
Kidney International Reports
Kidney International Reports, Vol 2, Iss 5, Pp 836-843 (2017)
Kidney International Reports
Kidney International Reports, Vol 2, Iss 5, Pp 836-843 (2017)
Introduction Patients undergoing on-pump cardiac surgery are at an increased risk of acute kidney injury. QPI-1002, a small interfering ribonucleic acid, is under clinical development for the prevention of acute kidney injury. The safety, tolerabilit
Autor:
Hagar Kalinski, Anat Brafman, Alexander Faerman, Ruben M. Sandoval, Hagit Ashush, Shai Erlich, Pierre C. Dagher, Silvia B. Campos, James D. Thompson, Rami Skaliter, Eduard Fridman, Simon J. Atkinson, Elena Feinstein, Bruce A. Molitoris
Publikováno v:
Journal of the American Society of Nephrology. 20:1754-1764
Proximal tubule cells (PTCs), which are the primary site of kidney injury associated with ischemia or nephrotoxicity, are the site of oligonucleotide reabsorption within the kidney. We exploited this property to test the efficacy of siRNA targeted to
Autor:
Arie Dagan, Shai Erlich, Jan W.M. Visser, Edward H. Schuchman, Silvia R.P. Miranda, Shimon Gatt
Publikováno v:
Blood. 93:80-86
The general utility of a novel, fluorescence-based procedure for assessing gene transfer and expression has been demonstrated using hematopoietic stem and progenitor cells. Lineage-depleted hematopoietic cells were isolated from the bone marrow or fe
Autor:
Mark E. Haskins, Shai Erlich, Silvia R.P. Miranda, Shimon Gatt, Edward H. Schuchman, V L Friedrich
Publikováno v:
Transplantation. 65:884-892
Background. Acid sphingomyelinase knock-out (ASMKO) mice are a model of types A and B Niemann-Pick disease. In the present study, we evaluated whether bone marrow transplantation (BMT) carried out on newborn ASMKO mice could prevent or alter the Niem
Autor:
Arie Dagan, V L Friedrich, Jan W.M. Visser, Shai Erlich, Silvia R.P. Miranda, Shimon Gatt, Edward H. Schuchman
Publikováno v:
Blood. 90:444-452
Types A and B Niemann-Pick disease (NPD) result from the deficient activity of the lysosomal hydrolase, acid sphingomyelinase (ASM). A long-term goal of our research is to evaluate the effects of bone marrow transplantation (BMT) and hematopoietic st
Autor:
Robert J. Desnick, Shai Erlich, Konrad Sandhoff, Klaus Ferlinz, Edward H. Schuchman, Daniel P. Perl, Colin L. Stewart, Kenichi Horinouchi, Charles L. Bisgaier
Publikováno v:
Nature Genetics. 10:288-293
Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). An animal model of NPD has been created by gene targeting. In affected animals, the disease followed a severe, neurodegenerative course and de
Autor:
Douglas J. Kornbrust, Shai Erlich, Elisabeth C.R. Solano, James D. Thompson, Bruce A. Molitoris, David J. Schneider, Jeffrey W.-D. Foy, Elena Feinstein
Publikováno v:
Nucleic acid therapeutics. 22(4)
We report the toxicological and pharmacokinetic properties of the synthetic, small interfering RNA I5NP following intravenous administration in rodents and nonhuman primates. I5NP is designed to act via the RNA interference (RNAi) pathway to temporar
Publikováno v:
Gene therapy. 7(20)
Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). Currently, no treatment is available for either form of NPD. Using the ASM knockout (ASMKO) mouse model, we evaluated the effects of ex vivo h